AbbVie Sues to Protect Rinvoq from Generic Competition in the US Market
AbbVie (NYSE: ABBV) has initiated legal action in the US to safeguard its blockbuster drug...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity
AbbVie (NYSE: ABBV) has initiated legal action in the US to safeguard its blockbuster drug...